Qube Research & Technologies LTD Enanta Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

  • $82.3 Billion
  • Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 87,867 shares of ENTA stock, worth $633,521. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,867
Previous 161,679 45.65%
Holding current value
$633,521
Previous $929,000 47.79%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$4.82 - $8.49 $355,773 - $626,663
-73,812 Reduced 45.65%
87,867 $485,000
Q4 2024

Feb 14, 2025
BUY
$5.75 - $12.99 $233,795 - $528,173
40,660 Added 33.6%
161,679 $929,000
Q3 2024

Nov 14, 2024
BUY
$10.05 - $16.54 $615,411 - $1.01 Million
61,235 Added 102.43%
121,019 $1.25 Million
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $489,672 - $729,153
-42,841 Reduced 41.75%
59,784 $775,000
Q1 2024

May 14, 2024
SELL
$10.08 - $17.46 $868,926 - $1.51 Million
-86,203 Reduced 45.65%
102,625 $1.79 Million
Q4 2023

Feb 13, 2024
BUY
$8.18 - $10.78 $614,776 - $810,181
75,156 Added 66.12%
188,828 $1.78 Million
Q3 2023

Nov 13, 2023
BUY
$11.09 - $22.13 $754,962 - $1.51 Million
68,076 Added 149.3%
113,672 $1.27 Million
Q2 2023

Aug 14, 2023
BUY
$20.68 - $39.85 $619,200 - $1.19 Million
29,942 Added 191.27%
45,596 $975,000
Q1 2023

May 15, 2023
SELL
$38.82 - $54.59 $300,544 - $422,635
-7,742 Reduced 33.09%
15,654 $633,000
Q4 2022

Feb 14, 2023
SELL
$40.77 - $53.73 $460,823 - $607,310
-11,303 Reduced 32.57%
23,396 $1.09 Million
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $1.42 Million - $2.1 Million
29,414 Added 556.56%
34,699 $1.8 Million
Q2 2022

Aug 15, 2022
SELL
$38.13 - $76.93 $153,206 - $309,104
-4,018 Reduced 43.19%
5,285 $250,000
Q1 2022

May 09, 2022
BUY
$56.06 - $74.11 $46,193 - $61,066
824 Added 9.72%
9,303 $662,000
Q4 2021

Feb 01, 2022
BUY
$60.19 - $97.37 $510,351 - $825,600
8,479 New
8,479 $634,000
Q1 2020

May 15, 2020
SELL
$40.22 - $62.0 $325,621 - $501,952
-8,096 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$57.95 - $66.61 $469,163 - $539,274
8,096 New
8,096 $500,000

Others Institutions Holding ENTA

# of Institutions
112
Shares Held
18.8M
Call Options Held
5.6K
Put Options Held
13.9K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $149M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email